RA0128

antibody from Oursmab
Targeting: CD7 GP40, LEU-9, Tp40, TP41
Provider product page for RA0128
Western blot
ELISA
Immunocytochemistry
Flow cytometry
Functional assay

Antibody data

Product number
RA0128 - Provider product page
Provider
Oursmab
Product name
Grisnilimab (Biosimilar Reference Antibody) (CD7)
Antibody type
Monoclonal
Description
Grisnilimab is an investigational immunoglobulin G2a (IgG2a) monoclonal antibody targeting CD7. It is classified as an anti-CD7 monoclonal antibody and is associated with research into Wilms' tumor (WT1), a pediatric kidney cancer. The designation "(WT1)" likely refers to the Wilms' tumor 1 gene/protein context of its study, not its direct target.
Reactivity
Human
Isotype
IgG
Vial size
100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg
Concentration
Bottled at the concentration indicated on the vial.
Storage
Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.
CD7 protein structure - RA0128 shown in red.